AAP
VYNT

Ardsley Advisory Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Ardsley Advisory Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$117K – 199
2015
Q3 		$117K Sell
100
-167
-63% -$256K 0.03% 138
2015
Q2 		$470K Sell
267
-204
-43% -$317K 0.06% 112
2015
Q1 		$552K Buy
471
+138
+41% +$163K 0.08% 119
2014
Q4 		$334K Buy
+333
New +$334K 0.05% 146
2014
Q3 		– Sell
-67
Closed -$113K – 267
2014
Q2 		$113K Buy
+67
New +$128K 0.01% 235
2014
Q1 		– Sell
-183
Closed -$379K – 278
2013
Q4 		$379K Buy
+183
New +$395K 0.05% 110

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QGM
Quality Growth Management Rancho Santa Fe, California $88.9M AUM
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Ardsley Advisory Partners's VYNT Position: Q4 2015 in Review

Ardsley Advisory Partners sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q4 2015, closing a stake of 100 shares — an estimated $117K sold.

Ardsley Advisory Partners first reported a position in VYNT in Q4 2013 and held it in 6 quarters. The position peaked at $552K in Q1 2015. 40 funds tracked by Wall St. Rank hold VYNT as of Q4 2015.

  • Ardsley Advisory Partners reported no remaining Vyant Bio, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Ardsley Advisory Partners sold 100 Vyant Bio, Inc. Common Stock shares in Q4 2015, an estimated $117K.
  • Ardsley Advisory Partners first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 6 quarters.
  • Ardsley Advisory Partners's Vyant Bio, Inc. Common Stock position peaked at $552K in Q1 2015.
  • 40 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q4 2015.

Based on Ardsley Advisory Partners's 13F filing for Q4 2015, filed 16 Feb 2016.